Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer

Yan Sun, Jin Wan Wang, Yong Yu Liu, Qi Tao Yu, Yi Ping Zhang, Kai Li, Li Yan Xu, Su Xia Luo, Feng Zhan Qin, Zheng Tang Chen, Wen Chao Liu, Qing Hua Zhou, Qiang Chen, Ke Jun Nan, Xiao Qing Liu, Wei Liu, Hou Jie Liang, Hui Shan Lu, Xiu Wen Wang, Jie Jun WangShu Ping Song, Yuan Rong Tu, Jing Min Zhou, Wei Lian Li, Chen Yao

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term results of a randomized, double-blind, and placebo-controlled phase III trial: Endostar (rh-endostatin) versus placebo in combination with vinorelbine and cisplatin in advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences